Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma

American Journal of Pathology

Volumn 158, Issue 2, 2001, Pages 735-743

  Slaton, Joel W ^a   Inoue, Keiji ^a   Perrotte, Paul ^a   El Naggar, Adel K ^a   Swanson, David A ^a   Fidler, Isaiah J ^a   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD34 ANTIGEN; GELATINASE A; GELATINASE B; INTERLEUKIN 8; UVOMORULIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CARCINOMA; METASTASIS; MICROVASCULATURE; MULTIVARIATE ANALYSIS; NEPHRECTOMY; OLIGONUCLEOTIDE PROBE; PLOIDY; PRIORITY JOURNAL;

EID: 0035131552     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64016-3     Document Type: Article

References (79)

1. Cancer statistics, CA
2. Renal cell carcinoma: Tumor size, stage and survival
3. Prognostic significance of morphologic parameters in renal cell carcinoma
4. Prognostic value of nuclear grade of renal cell carcinoma
5. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma
6. DNA flow cytometry as a predictor of stage I renal cell carcinoma
7. Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma
8. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma
9. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: An immunohistochemical study correlating grading, staging, and proliferation markers
10. Clinical outcome in localized renal cell carcinomas related to immunoexpression of proliferating cell nuclear antigen, Ki-67 antigen, and tumor size
11. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma
12. Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma
13. Expression of basic fibroblast growth factor in primary human renal tumors correlation with poor survival
14. Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patients
15. Renal cell carcinoma: Relevance of angiogenetic factors
16. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor placenta growth factor in renal cell carcinoma associated with angiogenesis
17. Vascular endothelial growth factor expression is increased in renal cell carcinoma
18. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma
19. Expression of metalloproteinases 2 and 9 and their inhibitors in renal cell carcinoma
20. Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma
21. E-cadherin expression in renal cell cancer and its significance in metastasis and survival
22. Genetic control of cancer metastasis
23. A rapid colorimetric in situ hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr-1 in mouse colon carcinoma cells
24. A rapid colorimetric in situ technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinoma
25. Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma
26. Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinoma
27. Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in human gastric carcinoma
28. Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma
29. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers: A novel potential predictor of pathologic stage
30. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma
31. Acridine orange flow cytometric analysis of renal cell carcinoma. Clinicopathological implications of RNA content
32. Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis
33. Tumor angiogenesis metastasis correlation in invasive breast carcinoma
34. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells
35. Basic fibroblast growth factor fused to a signal peptide transforms cells
36. Vascular endothelial growth factor is a secreted angiogenic mitogen
37. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MNDCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor
38. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique
39. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen
40. Molecular cloning characterization of the human E-cadherin cDNA
41. Improved tools for biological sequence comparison
42. Automated molecular pathology: One hour in situ DNA hybridization
43. Chemical synthesis biological studies on mutated gene-control regions
44. Complete one-hour immunocytochemistry based on capillary action
45. Regression models life tables
46. Critical factors in the biology of human cancer metastasis twenty-eighth GHA Clowes Memorial Award lecture
47. In vivo selection of highly metastatic cells from surgical specimens of different human colon carcinomas implanted into nude mice
48. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy
49. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis recurrence
50. Microvessel density, endothelial cell proliferation and tumor cell proliferation in human colorectal adenocarcinoma
51. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
52. Clinical significance of tumor angiogenesis with localized renal cell carcinoma
53. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma
54. Microvessel density in renal cell carcinoma: Lack of prognostic significance
55. Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis
56. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast
57. Expression of growth factors, growth-inhibiting factors, and their receptors in invasire breast cancer II: Correlations with proliferation angiogenesis
58. Interieukin-8 and MCAF: Novel leukocyte recruitment and activating cytokines
59. Interleukin-8. A corneal factor that induces neovascularization
60. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas
61. Cadherin cell adhesion receptor as a morphogenic regulator
62. Expression of E-cadherin, a- b- catenins in human gastric carcinoma: Correlation with histology and tumor progression
63. Correlation of E-cadherin expression with differentiation grade and histotogical type in breast carcinoma
64. Expression of E-cadherin cell adhesion molecule in human breast cancer tissues and its relationship to metastasis
65. E-cadherin expression in squamous carcinomas of the head and neck: Inverse correlation with tumor de differentiation and lymph node metastasis
66. Expression of E- and P-cadherin in gastric carcinoma
67. Tumor invasion and metastasis - Role of the extracellular matrix: Rhoads Memorial Award lecture
68. Stromelysin/transin and tumor progression
69. The matrix metalloproteinases their inhibitors
70. Type IV collagenase in tumor invasion metastases
71. Metalloproteinases cancer invasion
72. Increased expression of the MR 72,000 type IV collagenase in human colonic adenocarcinoma
73. Stromal expression of 72-kDa type IV collagenase (MMP-2) TIMP-2 mRNAs in colorectal neoplasia
74. Type IV collagenase in invasive tumors
75. The matrix metalloproteinases and their inhibitors
76. Tumor cell invasion by TIMP-2
77. Inhibition of tumor invasion of smooth muscle cell layer by recombinant human metalloproteinase inhibitor